The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis

NCT04638517 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

29

Enrollment

OTHER

Sponsor class

Stopped Data Safety Monitoring Board recommended cessation due to futility

Conditions

Pulmonary Fibrosis
Telomere Shortening
Telomere Disease
Dyskeratosis Congenita

Interventions

DRUG: Danazol
DRUG: Placebo

Sponsor

The University of Queensland